Women's CAD risk, treatment are neglected, researchers argue

07/29/2013 | MedPage Today (free registration)

The risk of coronary artery disease remains under-appreciated in female patients, who suffer a disproportionate amount of microvascular disease and are much less likely than men to receive preventive treatments and recommendations despite facing higher mortality and morbidity rates, according to a review published in Global Heart. "Further research regarding the pathophysiology of CAD in women, diagnosis, and treatment strategies specific to women is required," wrote Drs. Martha Gulati and Kavita Sharma. "CAD is not a 'man's only' disease, and we eagerly await future studies that examine its unique presence in women."

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD